Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolevamer vs Vancomycin and Metronidazole in C. difficile-Associated Diarrhea
NCT00106509Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2005
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of tolevamer in Clostridioides difficile infection (CDI) (3 arms), sponsored by Sanofi. Primary endpoint: Resolution of diarrhea. Started Mar 2005; status: completed.
02
Drugs
tolevamer
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT00106509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106509.